相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Left Ventricular Mass Change After Anthracycline Chemotherapy
Jennifer H. Jordan et al.
CIRCULATION-HEART FAILURE (2018)
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Daniela Cardinale et al.
EUROPEAN JOURNAL OF CANCER (2018)
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Monica Samuel Avila et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction
Michael F. Bode et al.
THROMBOSIS RESEARCH (2018)
Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
Thiago Ferreira de Souza et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Doxorubicin-induced chronic dilated cardiomyopathy-the apoptosis hypothesis revisited
Cynthia Kankeu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia
Thomas Scott Bowen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Cardiac troponins: from myocardial infarction to chronic disease
Kyung Chan Park et al.
CARDIOVASCULAR RESEARCH (2017)
Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy
Marie-Pierre Jolly et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2017)
Developmental Regulation of Mitochondria! Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics
Kristopher A. Sarosiek et al.
CANCER CELL (2017)
Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidence
Philip J. Atherton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
The pathogenesis and treatment of cardiac atrophy in cancer cachexia
Kate T. Murphy
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Cancer Therapy-Related Cardiac Dysfunction and Heart Failure Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging
Michelle W. Bloom et al.
CIRCULATION-HEART FAILURE (2016)
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shlomit Strulov Shachar et al.
EUROPEAN JOURNAL OF CANCER (2016)
Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy
Roy B. Mukku et al.
JOURNAL OF CARDIAC FAILURE (2016)
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
Markus Rasanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
Nobuhiko Nakamura et al.
ANNALS OF HEMATOLOGY (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
Noemi Pavo et al.
HEART (2015)
Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy
Kisuk Min et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Sexual Dimorphism of Doxorubicin-Mediated Cardiotoxicity Potential Role of Energy Metabolism Remodeling
Maryline Moulin et al.
CIRCULATION-HEART FAILURE (2015)
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Sue C. Bodine et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle
Andreas N. Kavazis et al.
JOURNAL OF APPLIED PHYSIOLOGY (2014)
The role of ubiquitin ligases in cardiac disease
Monte S. Willis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin
Yanpeng Wang et al.
CARDIOVASCULAR RESEARCH (2013)
Role of the Ubiquitin Proteasome System in the Heart
Julia Pagan et al.
CIRCULATION RESEARCH (2013)
Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity
Brian C. Jensen et al.
PHARMACOGENOMICS (2013)
Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease
Brandon C. Drafts et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Mechanical Unloading Activates FoxO3 to Trigger Bnip3-Dependent Cardiomyocyte Atrophy
Dian J. Cao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
Tomas G. Neilan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart
Balindiwe J. N. Sishi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Elevated Myocardial Enzymes and Natriuretic Peptides in Anorexia Nervosa: Prototypic Condition for the Pathophysiology of Cachexia?
Arne Zastrow et al.
CARDIOLOGY (2011)
Taking pressure off the heart: the ins and outs of atrophic remodelling
Kedryn K. Baskin et al.
CARDIOVASCULAR RESEARCH (2011)
Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy
Erica C. Campos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
S. Luminari et al.
ANNALS OF ONCOLOGY (2010)
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms
Giulia Mearini et al.
CARDIOVASCULAR RESEARCH (2010)
Muscle ring finger 1 mediates cardiac atrophy in vivo
Monte S. Willis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes
Yasuhiro Yamamoto et al.
CARDIOVASCULAR RESEARCH (2008)
Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3
Jens Fielitz et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular and cellular mechanisms of anthracycline cardiotoxicity
Billy Chen et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfalls
J. Robert
CELL BIOLOGY AND TOXICOLOGY (2007)
Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy
LH Li et al.
CIRCULATION (2006)
New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics
Malgorzata Tokarska-Schlattner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
V Kedar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle
EJ Stevenson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
D Cardinale et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
